These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16259013)

  • 1. Prostaglandin D2 synthase and its post-translational modifications in neurological disorders.
    Lescuyer P; Gandini A; Burkhard PR; Hochstrasser DF; Sanchez JC
    Electrophoresis; 2005 Dec; 26(23):4563-70. PubMed ID: 16259013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related increase of prostaglandin D(2) synthase concentration and glycation in ovine cerebrospinal fluid.
    Chen CP; Chen RL; Preston JE
    Exp Gerontol; 2009 Oct; 44(10):639-45. PubMed ID: 19595756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central nervous system lipocalin-type prostaglandin D2-synthase is correlated with orexigenic neuropeptides, visceral adiposity and markers of the hypothalamic-pituitary-adrenal axis in obese humans.
    Elias E; Benrick A; Behre CJ; Ekman R; Zetterberg H; Stenlöf K; Wallenius V
    J Neuroendocrinol; 2011 Jun; 23(6):501-7. PubMed ID: 21438929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased intrathecal synthesis of prostaglandin D2 synthase in the cerebrospinal fluid of patients with acute inflammatory demyelinating polyneuropathy.
    Huang YC; Lyu RK; Tseng MY; Chang HS; Hsu WC; Kuo HC; Chu CC; Wu YR; Ro LS; Huang CC; Chen CM
    J Neuroimmunol; 2009 Jan; 206(1-2):100-5. PubMed ID: 19049845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Charge microheterogeneity of the beta-trace proteins (lipocalin-type prostaglandin D synthase) in the cerebrospinal fluid of patients with neurological disorders analyzed by capillary isoelectrofocusing.
    Hiraoka A; Seiki K; Oda H; Eguchi N; Urade Y; Tominaga I; Baba K
    Electrophoresis; 2001 Oct; 22(16):3433-7. PubMed ID: 11669522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of prostaglandin D synthase by ceramic- and size exclusion chromatography.
    Schlatterer JC; Baeker R; Schlatterer B; Klose J; Kehler W; Schlatterer K
    Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):80-9. PubMed ID: 16997134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin D synthase (beta-trace) in meningeal hemangiopericytoma.
    Kawashima M; Suzuki SO; Yamashima T; Fukui M; Iwaki T
    Mod Pathol; 2001 Mar; 14(3):197-201. PubMed ID: 11266526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrosative stress with HIV dementia causes decreased L-prostaglandin D synthase activity.
    Li W; Malpica-Llanos TM; Gundry R; Cotter RJ; Sacktor N; McArthur J; Nath A
    Neurology; 2008 May; 70(19 Pt 2):1753-62. PubMed ID: 18077799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipocalin-like prostaglandin D synthase in subretinal fluid of detached retinas in humans.
    Jaggi GP; Flammer J; Huber AR; Killer HE
    Retina; 2008 Jun; 28(6):858-63. PubMed ID: 18536603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipocalin-type prostaglandin D synthase (beta-trace) is upregulated in the alphaB-crystallin-positive oligodendrocytes and astrocytes in the chronic multiple sclerosis.
    Kagitani-Shimono K; Mohri I; Oda H; Ozono K; Suzuki K; Urade Y; Taniike M
    Neuropathol Appl Neurobiol; 2006 Feb; 32(1):64-73. PubMed ID: 16409554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of brain cell death associated proteins in human post-mortem cerebrospinal fluid.
    Burgess JA; Lescuyer P; Hainard A; Burkhard PR; Turck N; Michel P; Rossier JS; Reymond F; Hochstrasser DF; Sanchez JC
    J Proteome Res; 2006 Jul; 5(7):1674-81. PubMed ID: 16823975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases.
    Yin GN; Lee HW; Cho JY; Suk K
    Brain Res; 2009 Apr; 1265():158-70. PubMed ID: 19368810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteoform analysis of lipocalin-type prostaglandin D-synthase from human cerebrospinal fluid by isoelectric focusing and superficially porous liquid chromatography with Fourier transform mass spectrometry.
    Zhang J; Corbett JR; Plymire DA; Greenberg BM; Patrie SM
    Proteomics; 2014 May; 14(10):1223-31. PubMed ID: 24678018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of recombinant human lipocalin-type prostaglandin D synthase/beta-trace in canine.
    Li W; Mase M; Inui T; Shimoda M; Isomura K; Oda H; Yamada K; Urade Y
    Neurosci Res; 2008 Jul; 61(3):289-93. PubMed ID: 18471915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid protein reactions during non-neurological surgery.
    Anckarsäter R; Vasic N; Jidéus L; Kristiansson M; Zetterberg H; Blennow K; Anckarsäter H
    Acta Neurol Scand; 2007 Apr; 115(4):254-9. PubMed ID: 17376123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin D synthase (beta trace) levels in sleep apnea patients with and without sleepiness.
    Barceló A; de la Peña M; Barbé F; Pierola J; Bosch M; Agustí AG
    Sleep Med; 2007 Aug; 8(5):509-11. PubMed ID: 17512779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seminal plasma lipocalin-type prostaglandin D synthase: a potential new marker for the diagnosis of obstructive azoospermia.
    Heshmat SM; Mullen JB; Jarvi KA; Soosaipillai A; Diamandis EP; Hamilton RJ; Lo KC
    J Urol; 2008 Mar; 179(3):1077-80. PubMed ID: 18206953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An aberrant protein complex in CSF as a biomarker of Alzheimer disease.
    Lovell MA; Lynn BC; Xiong S; Quinn JF; Kaye J; Markesbery WR
    Neurology; 2008 Jun; 70(23):2212-8. PubMed ID: 18448869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-translational modification regulates prostaglandin D2 synthase apoptotic activity: characterization by site-directed mutagenesis.
    Ragolia L; Hall CE; Palaia T
    Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):25-32. PubMed ID: 17259069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CSF biomarkers: proteomics investigations and clinical applications in neurodegenerative disorders].
    Gabelle A; Roche S; Lehmann S
    Rev Neurol (Paris); 2009 Mar; 165(3):213-22. PubMed ID: 18808768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.